2026 Optometrist Report
Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.
New Content
Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer
Philadelphia, PA
Clinical Impact of Demodex Blepharitis with Interactive Calculator
Learn how to recognize, fully treat, and follow up Demodex blepharitis before it compromises cataract and refractive outcomes.
The Ultimate Guide to TOTAL30® Multifocal for Astigmatism
Drs. Cifuentes and Lagunas offer insight into TOTAL30® Multifocal for Astigmatism, a modern solution designed for presbyopic patients with astigmatism, providing comfort and clear vision for both distance and near tasks.1
In the Hot Seat: A Live Q&A Regarding All Things Retina
Carolyn Majcher, OD, FAAO, FORS, answers questions from Eyes On Retina 2026 attendees regarding anything and everything retina.
Topics
Advancements in Non-Invasive Imaging for Dry Eye Disease
Stabilizing the Tear Film Prior to Cataract Surgery
Sit down with Drs. Preeya K. Gupta and Vance Thompson to review approaches for efficiently addressing tear film instability before cataract surgery.
FDA orders NAION risk potential added to GLP-1 RA warning labels
Federal agency issues new safety warning following new evidence; will now require all manufactures to update medication labels.
Harrow debuts prescribing and access pharmacy platform
Company positions HarrowRx as a first-of-its-kind platform in the U.S. bringing prescribing, fulfillment, and patient support into one place for its entire branded portfolio.
Cloudbreak Pharma releases positive phase 3 topline data on pterygium therapy
Data demonstrate durable reductions in pterygium vascularity with a favorable safety profile; company intends to review findings with FDA.
Glaukos and RevOpsis partner on retina tri-specific therapy development, commercialization
Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer
Join Drs. Rishi Singh and Donald D'Amico to review the results of the phase 3 BRUNELLO trial of Remigromig for DME and implications for the BAROLO trial.
Barriers to Oculomics and How to Overcome Them
Consider key challenges in the adoption and implementation of oculomics, such as settling regulatory, legal, and reimbursement questions, and more.
Clinical Impact of Demodex Blepharitis with Interactive Calculator
Learn how to recognize, fully treat, and follow up Demodex blepharitis before it compromises cataract and refractive outcomes.
Clinical Specialties
The Ultimate Guide to TOTAL30® Multifocal for Astigmatism
In the Hot Seat: A Live Q&A Regarding All Things Retina
Advancements in Non-Invasive Imaging for Dry Eye Disease
2026 Optometrist Report
Download the free report to understand how optometrists today are advancing their careers, managing their practices, and adapting to evolving trends in eyecare.
How DTC Advertising is Driving Presbyopia Drop Conversations in Practice
Joins Drs. Coats, Davison, Ramsey and Schaeffer to review how direct-to-consumer (DTC) advertising impacts patient conversations about presbyopia drops.
How I Made CareCredit Simple for My Team and Patients
Dr. Brianna Rhue shares practical ways eyecare practice teams can simplify CareCredit for staff and patients through training, workflows, patient conversations, and performance tracking.
Careers
The Impact of Presbyopia Drops on Optical Sales
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
Beyond the Sales Rep: Understanding Who’s Who in Industry
The Ultimate Guide to TOTAL30® Multifocal for Astigmatism
Drs. Cifuentes and Lagunas offer insight into TOTAL30® Multifocal for Astigmatism, a modern solution designed for presbyopic patients with astigmatism, providing comfort and clear vision for both distance and near tasks.1
